Yunnan, China

Jingkun Wang

USPTO Granted Patents = 2 

Average Co-Inventor Count = 11.6

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Yunnan, CN (2019)
  • Kunming, CN (2020)

Company Filing History:


Years Active: 2019-2020

Loading Chart...
2 patents (USPTO):Explore Patents

Title: **The Innovations of Jingkun Wang: A Focus on Medications and Crystal Forms**

Introduction

Jingkun Wang is an accomplished inventor based in Yunnan, China. With a strong background in medicinal chemistry, he has developed significant patents that contribute to the field of medicine and chemical industry.

Latest Patents

Jingkun Wang holds two notable patents. The first is titled **"Polymorph of triaryldimethylpiperazine dihydrochloride and preparation method and application thereof."** This application discloses five polymorph forms (B, P, F, J, O) of a specific compound that has shown promise in the manufacture of medications aimed at preventing or treating mood disorders or diseases related to δ opioid receptors. The second patent is the **"Crystal forms of scutellarin aglycone and preparation thereof."** This invention pertains to multiple crystal forms of scutellarin aglycone, which presents valuable solutions to issues related to poor oral absorption and low bioavailability. The applications of these crystal forms include the manufacture of medications for cardiovascular or cerebrovascular diseases, rheumatic arthritis, and stroke sequelae.

Career Highlights

Jingkun Wang has made significant contributions to his field during his tenure at various institutions, particularly at the Yunnan Institute of Materia Medica and Hlk Pharmaceuticals Co., Ltd. His work has led to advancements in drug formulation and development, focusing on enhancing the efficacy and stability of medications.

Collaborations

Throughout his career, Jingkun has collaborated with several talented individuals, including Zeren Wang and Zhaoyun Zhu. These partnerships have led to innovative approaches in medicinal chemistry and further strengthened the impact of their research.

Conclusion

Jingkun Wang continues to innovate within the pharmaceutical industry through his remarkable patents and collaborations. His contributions are instrumental in addressing significant medical challenges and improving the quality of treatments available for various medical conditions. His work exemplifies the essence of innovation in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…